202 related articles for article (PubMed ID: 28125507)
21. Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease.
Hiremathad A; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA
Eur J Med Chem; 2018 Mar; 148():255-267. PubMed ID: 29466775
[TBL] [Abstract][Full Text] [Related]
22. The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis.
Sugimoto H
Chem Biol Interact; 2008 Sep; 175(1-3):204-8. PubMed ID: 18577377
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
Muñoz-Ruiz P; Rubio L; García-Palomero E; Dorronsoro I; del Monte-Millán M; Valenzuela R; Usán P; de Austria C; Bartolini M; Andrisano V; Bidon-Chanal A; Orozco M; Luque FJ; Medina M; Martínez A
J Med Chem; 2005 Nov; 48(23):7223-33. PubMed ID: 16279781
[TBL] [Abstract][Full Text] [Related]
24. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Wang ZM; Cai P; Liu QH; Xu DQ; Yang XL; Wu JJ; Kong LY; Wang XB
Eur J Med Chem; 2016 Nov; 123():282-297. PubMed ID: 27484514
[TBL] [Abstract][Full Text] [Related]
25. Novel Multitarget Hybrid Compounds for the Treatment of Alzheimer's Disease.
Michalska P; Buendia I; Del Barrio L; Leon R
Curr Top Med Chem; 2017; 17(9):1027-1043. PubMed ID: 27697052
[TBL] [Abstract][Full Text] [Related]
26. Multitarget drug design strategy in Alzheimer's disease: focus on cholinergic transmission and amyloid-β aggregation.
Simoni E; Bartolini M; Abu IF; Blockley A; Gotti C; Bottegoni G; Caporaso R; Bergamini C; Andrisano V; Cavalli A; Mellor IR; Minarini A; Rosini M
Future Med Chem; 2017 Jun; 9(10):953-963. PubMed ID: 28632446
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.
Catto M; Pisani L; Leonetti F; Nicolotti O; Pesce P; Stefanachi A; Cellamare S; Carotti A
Bioorg Med Chem; 2013 Jan; 21(1):146-52. PubMed ID: 23199476
[TBL] [Abstract][Full Text] [Related]
28. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
da Silva CH; Campo VL; Carvalho I; Taft CA
J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease.
Dias KS; de Paula CT; Dos Santos T; Souza IN; Boni MS; Guimarães MJ; da Silva FM; Castro NG; Neves GA; Veloso CC; Coelho MM; de Melo IS; Giusti FC; Giusti-Paiva A; da Silva ML; Dardenne LE; Guedes IA; Pruccoli L; Morroni F; Tarozzi A; Viegas C
Eur J Med Chem; 2017 Apr; 130():440-457. PubMed ID: 28282613
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
32. Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease.
Muñoz-Torrero D
Curr Med Chem; 2008; 15(24):2433-55. PubMed ID: 18855672
[TBL] [Abstract][Full Text] [Related]
33. Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapy.
Zheng H; Fridkin M; Youdim MB
Curr Drug Targets; 2012 Jul; 13(8):1089-106. PubMed ID: 22676912
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
35. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
[TBL] [Abstract][Full Text] [Related]
36. From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease.
Chierrito TPC; Pedersoli-Mantoani S; Roca C; Requena C; Sebastian-Perez V; Castillo WO; Moreira NCS; Pérez C; Sakamoto-Hojo ET; Takahashi CS; Jiménez-Barbero J; Cañada FJ; Campillo NE; Martinez A; Carvalho I
Eur J Med Chem; 2017 Oct; 139():773-791. PubMed ID: 28863358
[TBL] [Abstract][Full Text] [Related]
37. Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease.
Damar U; Gersner R; Johnstone JT; Schachter S; Rotenberg A
Med Hypotheses; 2017 Feb; 99():57-62. PubMed ID: 28110700
[TBL] [Abstract][Full Text] [Related]
38. 6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
Semenov VE; Zueva IV; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
ChemMedChem; 2015 Nov; 10(11):1863-74. PubMed ID: 26412714
[TBL] [Abstract][Full Text] [Related]
39. Hybrid-based multi-target ligands for the treatment of Alzheimer's disease.
Rampa A; Belluti F; Gobbi S; Bisi A
Curr Top Med Chem; 2011 Nov; 11(22):2716-30. PubMed ID: 22039875
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Xie SS; Wang XB; Li JY; Yang L; Kong LY
Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
